Fabrication of PAMAM antimicrobial monolayer via UV induced grafting on the surface of polyethylene terephthalate

Poly (amidoamine) (PAMAM) with 3rd and 5th generation was covalently grafted as the contact active biocidal agent on the surface of polyethylene terephthalate (PET) with the help of UV induced carbene chemistry (PAMAM-g-PET). The graft density and the surface roughness were controlled by turning UV irradiation time and the PAMAM generation. The PAMAM graft monolayer was characterized via the contact angle, XPS, nanoIR, SEM and AFM. The antibacterial ability of PAMAM-g-PET was evaluated ex-vivo with the help of laser scanning confocal microscope (CLSM), and the results indicated that the decorated PET was able to kill both S. aureus and E. coli in the aqueous environment. Increasing the surface graft concentration and using the dendrimer with higher generation enhanced the lethality towards the bacterial. The decorated film was still able to kill the contact bacterial strain when the cationic primary amine groups were shielded by acetyl chloride, however, the bacterial in the suspension was hardly affected in this case. The un-selectivity and instantaneity of carbene chemistry endowed this grafting strategy the potential to be extended to other organic substances.

Rapid, Ultrasensitive, and Quantitative Detection of SARS-CoV-2 Using Antisense Oligonucleotides Directed Electrochemical Biosensor Chip

A large-scale diagnosis of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is essential to downregulate its spread within as well as across communities and mitigate the current outbreak of the pandemic novel coronavirus disease 2019 (COVID-19). Herein, we report the development of a rapid (less than 5 min), low-cost, easy-to-implement, and quantitative paper-based electrochemical sensor chip to enable the digital detection of SARS-CoV-2 genetic material. The biosensor uses gold nanoparticles (AuNPs), capped with highly specific antisense oligonucleotides (ssDNA) targeting viral nucleocapsid phosphoprotein (N-gene). The sensing probes are immobilized on a paper-based electrochemical platform to yield a nucleic-acid-testing device with a readout that can be recorded with a simple hand-held reader. The biosensor chip has been tested using samples collected from Vero cells infected with SARS-CoV-2 virus and clinical samples. The sensor provides a significant improvement in output signal only in the presence of its target-SARS-CoV-2 RNA-within less than 5 min of incubation time, with a sensitivity of 231 (copies μL-1)-1 and limit of detection of 6.9 copies/μL without the need for any further amplification. The sensor chip performance has been tested using clinical samples from 22 COVID-19 positive patients and 26 healthy asymptomatic subjects confirmed using the FDA-approved RT-PCR COVID-19 diagnostic kit. The sensor successfully distinguishes the positive COVID-19 samples from the negative ones with almost 100% accuracy, sensitivity, and specificity and exhibits an insignificant change in output signal for the samples lacking a SARS-CoV-2 viral target segment (e.g., SARS-CoV, MERS-CoV, or negative COVID-19 samples collected from healthy subjects). The feasibility of the sensor even during the genomic mutation of the virus is also ensured from the design of the ssDNA-conjugated AuNPs that simultaneously target two separate regions of the same SARS-CoV-2 N-gene.

Impedimetric aptasensor for the label-free and selective detection of Interleukin-6 for colorectal cancer screening

Despite the fact that cancer research has experienced important advances and remarkable improvement in the curing processes during the last decades, this disease still occupies a leading position among the causes of death worldwide. It has been demonstrated that there is an interconnection between the overexpression of interleukin-6 cytokine and the tumor growth, metastasis, and therapeutic resistance in several types of malignancies. Herein, a highly sensitive and selective aptasensor for quantitative detection of interleukin-6 was developed by using a glassy carbon electrode modified with p-aminobenzoic acid, p-aminothiophenol and gold nanoparticles. A thio-terminated aptamer specific for interleukin-6 was immobilized on the surface of the modified electrode via the formation of gold-sulfur bonds. This DNA oligonucleotide was then used as a detection probe to capture the target protein at the biosensor surface allowing label-free detection by electrochemical impedance spectroscopy. The developed aptasensor showed a good linear response from 5 pgmL^-1 to 100 ngmL^-1 with a detection limit of 1.6 pgmL^-1, within the range of physiological concentration of the protein. The biosensor exhibited high selectivity and has been successfully used to detect interleukin-6 in blood samples collected from patients suffering of colorectal cancer, with excellent recoveries after the addition of known amount of the target protein.

Photochemically mediated synthesis of a gold colloid by dithizone and its application in the amperometric sensing of thiocyanate

Au–DTZH was synthesized by a one-step photochemical route and used for the amperometric sensing of thiocyanate. The modified electrode has a sensitivity of 16 nA nM⁻¹ and a limit of detection of 23.35 nM at a potential of 0.55 V vs. Ag/AgCl.

High-density assembly of chemiluminescence functionalized gold nanodots on multiwalled carbon nanotubes and their application as biosensing platforms

A one-step strategy was developed for high-density assembly of N-(aminobutyl)-N-(ethylisoluminol) (ABEI) functionalized gold nanodots onto the sidewalls of chitosan-grafted multiwalled carbon nanotubes (cs-MWCNTs) via the reduction of HAuCl4 with ABEI in the presence of cs-MWCNTs, resulting in novel hybrid nanomaterials with excellent chemiluminescence and electrochemiluminescence properties.